Written by HealthDay News
Updated on March 13, 2007
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate the safety and effectiveness of an investigational drug to treat fibromyalgia. Qualified participants with fibromyalgia will receive study-related physician visits, laboratory evaluations, and investigational medication at no cost. Participation could last up to six months.
The research site is in Danbury, Conn.
Athlete's Foot (Tinea Pedis)
Do you have athlete's foot, including symptoms of a scaly, itchy red rash on your feet or toes? This six-week study seeks healthy volunteers 12 years or older with athlete's foot. Participants will receive study related procedures and may qualify for compensation for time and travel.
The research site is in Ann Arbor, Mich.
This study will evaluate an EEG-guided treatment for major depression. Eligible participants will be offered psychiatric evaluation, antidepressant medication, and study-related laboratory tests at no cost. Currently-depressed individuals 18 and older who have tried at least three medications for depression without success, and are in good physical health may be included. Participants receive up to $400 for time and travel.
The research site is in Stanford, Calif.
Copyright 2007 Thomson CenterWatch. All rights reserved.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.